(Q44785713)
Statements
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101 (English)
Adamson PC
Blaney SM
Widemann BC
Kitchen B
Murphy RF
Hannah AL
Cropp GF
Patel M
Gillespie AF
Whitcomb PG
4 March 2004